(Q69638098)
Statements
Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung. EORTC Lung Cancer Cooperative Group (English)
G Anderson
M Clavel
J Smyth
M Gracia
A S Planting
O Dalesio
A Kirkpatrick